Literature DB >> 35063080

Treatment-induced hemophilic thrombosis?

Radoslaw Kaczmarek1, Roland W Herzog2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35063080      PMCID： PMC8822130          DOI： 10.1016/j.ymthe.2022.01.015

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

1.  Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?

Authors:  Glenn F Pierce; Radoslaw Kaczmarek; Declan Noone; Brian O'Mahony; David Page; Mark W Skinner
Journal:  Haemophilia       Date:  2020-09-10       Impact factor: 4.287

Review 2.  A Molecular Revolution in the Treatment of Hemophilia.

Authors:  John S S Butterfield; Kerry M Hege; Roland W Herzog; Radoslaw Kaczmarek
Journal:  Mol Ther       Date:  2019-11-13       Impact factor: 11.454

3.  Liver Gene Therapy: Reliable and Durable?

Authors:  Roland W Herzog; Glenn F Pierce
Journal:  Mol Ther       Date:  2019-10-17       Impact factor: 11.454

4.  Curing Hemophilia: Repeated Treatments versus a One-Off Fix.

Authors:  Ning Li; Radoslaw Kaczmarek
Journal:  Mol Ther       Date:  2020-04-17       Impact factor: 11.454

5.  Eliminating Panglossian thinking in development of AAV therapeutics.

Authors:  Radoslaw Kaczmarek; Glenn F Pierce; Declan Noone; Brian O'Mahony; David Page; Mark W Skinner
Journal:  Mol Ther       Date:  2021-11-10       Impact factor: 11.454
  5 in total
  2 in total

Review 1.  Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives.

Authors:  Samantha Pasca
Journal:  J Blood Med       Date:  2022-04-16

2.  Gene therapy - are we ready now?

Authors:  Radoslaw Kaczmarek
Journal:  Haemophilia       Date:  2022-05       Impact factor: 4.263
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.